XML 70 R52.htm IDEA: XBRL DOCUMENT v3.3.1.900
Subsidiary Guarantors for Credit Agreement, Term Loan and 2021 Notes (Tables) - Supplemental Guarantor Subsidiaries
12 Months Ended
Oct. 30, 2015
Condensed Financial Statements, Captions [Line Items]  
Supplemental Subsidiary Guarantor Condensed Consolidated Statement of Income
Condensed Consolidated Statement of Operations
Fiscal Year Ended October 30, 2015
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
1,801,405

 
$
2,330,469

 
$
(959,727
)
 
$
3,172,147

Cost of sales

 
1,339,541

 
1,732,574

 
(738,890
)
 
2,333,225

Product development, selling and administrative expenses
47,604

 
192,956

 
376,087

 
26

 
616,673

Impairment charges

 
160,988

 
1,177,253

 

 
1,338,241

Other (income) and expense
68

 
17,534

 
(24,205
)
 

 
(6,603
)
Operating (loss) income
(47,672
)
 
90,386

 
(931,240
)
 
(220,863
)
 
(1,109,389
)
Intercompany items
66,408

 
(107,484
)
 
48,415

 
(7,339
)
 

Loss on early debt retirement
(14,311
)
 

 

 

 
(14,311
)
Interest (expense) income, net
(63,138
)
 
6,769

 
2,940

 

 
(53,429
)
(Loss) income from operations before income taxes and equity in income of subsidiaries
(58,713
)
 
(10,329
)
 
(879,885
)
 
(228,202
)
 
(1,177,129
)
Provision (benefit) for income taxes
(3,807
)
 
17,886

 
(13,204
)
 

 
875

Equity in income of subsidiaries
(1,123,098
)
 
(39,946
)
 

 
1,163,044

 

(Loss) income from continuing operations
$
(1,178,004
)
 
$
(68,161
)
 
$
(866,681
)
 
$
934,842

 
$
(1,178,004
)
 
 
 
 
 
 
 
 
 
 
Comprehensive (loss) income
$
(1,318,796
)
 
$
(69,263
)
 
$
(1,019,963
)
 
$
1,089,226

 
$
(1,318,796
)

Condensed Consolidated Statement of Operations, As Adjusted
Fiscal Year Ended October 31, 2014
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
2,127,333

 
$
2,568,580

 
$
(917,603
)
 
$
3,778,310

Cost of sales
700

 
1,542,011

 
1,876,783

 
(765,261
)
 
2,654,233

Product development, selling and administrative expenses
60,942

 
236,233

 
311,711

 

 
608,886

Other (income) and expense
(473
)
 
12,667

 
(24,529
)
 

 
(12,335
)
Operating income (loss)
(61,169
)
 
336,422

 
404,615

 
(152,342
)
 
527,526

Intercompany items
64,185

 
(77,048
)
 
(29,099
)
 
41,962

 

Interest (expense) income, net
(63,639
)
 
6,750

 
1,541

 

 
(55,348
)
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries
(60,623
)
 
266,124

 
377,057

 
(110,380
)
 
472,178

Provision (benefit) for income taxes
(46,296
)
 
155,459

 
24,897

 

 
134,060

Equity in income of subsidiaries
352,445

 
165,942

 

 
(518,387
)
 

Income from continuing operations
$
338,118

 
$
276,607

 
$
352,160

 
$
(628,767
)
 
$
338,118

 
 
 
 
 
 
 
 
 
 
Comprehensive income
$
301,810

 
$
281,569

 
$
311,369

 
$
(592,938
)
 
$
301,810



Condensed Consolidated Statement of Operations, As Adjusted
Fiscal Year Ended October 25, 2013
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
2,745,565

 
$
3,702,376

 
$
(1,435,244
)
 
$
5,012,697

Cost of sales
(750
)
 
1,925,605

 
2,659,977

 
(1,185,264
)
 
3,399,568

Product development, selling and administrative expenses
50,443

 
294,952

 
310,753

 

 
656,148

Impairment charges

 
100,400

 
54,800

 

 
155,200

Other (income) and expense
(15,000
)
 
34,101

 
(52,750
)
 

 
(33,649
)
Operating income (loss)
(34,693
)
 
390,507

 
729,596

 
(249,980
)
 
835,430

Intercompany items
114,784

 
(79,519
)
 
(151,571
)
 
116,306

 

Interest (expense) income, net
(64,665
)
 
3,225

 
3,936

 

 
(57,504
)
Income from continuing operations before income taxes and equity in income of subsidiaries
15,426

 
314,213

 
581,961

 
(133,674
)
 
777,926

Provision (benefit) for income taxes
(42,174
)
 
207,602

 
75,739

 

 
241,167

Equity in income of subsidiaries
479,159

 
397,610

 

 
(876,769
)
 

Income from continuing operations
$
536,759

 
$
504,221

 
$
506,222

 
$
(1,010,443
)
 
$
536,759

 
 
 
 
 
 
 
 
 
 
Comprehensive income
$
518,266

 
$
505,329

 
$
486,689

 
$
(992,018
)
 
$
518,266

Supplemental Subsidiary Guarantor Condensed Consolidated Balance Sheet
Condensed Consolidating Balance Sheet
As of October 30, 2015
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 


Cash and cash equivalents
$
581

 
$
2,008

 
$
100,296

 
$

 
$
102,885

Accounts receivable, net

 
214,381

 
597,826

 
(134
)
 
812,073

Inventories

 
508,774

 
607,461

 
(108,310
)
 
1,007,925

Other current assets
58,441

 
15,610

 
71,508

 

 
145,559

Total current assets
59,022

 
740,773

 
1,377,091

 
(108,444
)
 
2,068,442

Property, plant and equipment, net
21,318

 
297,476

 
478,253

 
(5,015
)
 
792,032

Other assets:
 
 
 
 
 
 
 
 


Other intangible assets, net

 
207,891

 
47,819

 

 
255,710

Goodwill

 
346,348

 
8,273

 

 
354,621

Deferred income taxes
49,660

 

 
69,253

 

 
118,913

Other non-current assets
2,740,518

 
2,078,294

 
2,517,110

 
(7,213,194
)
 
122,728

Total other assets
2,790,178

 
2,632,533

 
2,642,455

 
(7,213,194
)
 
851,972

Total assets
$
2,870,518

 
$
3,670,782

 
$
4,497,799

 
$
(7,326,653
)
 
$
3,712,446

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Short-term borrowings, including current portion of long-term obligations
$
18,750

 
$

 
$
7,571

 
$

 
$
26,321

Trade accounts payable
3,342

 
96,891

 
175,556

 

 
275,789

Employee compensation and benefits
5,843

 
36,527

 
47,965

 

 
90,335

Advance payments and progress billings

 
100,312

 
149,795

 
(20,637
)
 
229,470

Accrued warranties

 
19,027

 
33,119

 

 
52,146

Other accrued liabilities
76,650

 
60,228

 
100,660

 
(12,261
)
 
225,277

Current liabilities of discontinued operations

 
11,582

 

 

 
11,582

Total current liabilities
104,585

 
324,567

 
514,666

 
(32,898
)
 
910,920

Long-term obligations
1,060,598

 

 
45

 

 
1,060,643

Other liabilities:
 
 
 
 
 
 
 
 


Liabilities for postretirement benefits
18,662

 
878

 

 

 
19,540

Accrued pension costs
159,594

 
8,406

 
7,699

 

 
175,699

Other non-current liabilities
81,595

 
8,325

 
35,715

 

 
125,635

Total other liabilities
259,851

 
17,609

 
43,414

 

 
320,874

Shareholders’ equity
1,445,484

 
3,328,606

 
3,939,674

 
(7,293,755
)
 
1,420,009

Total liabilities and shareholders’ equity
$
2,870,518

 
$
3,670,782

 
$
4,497,799

 
$
(7,326,653
)
 
$
3,712,446


Condensed Consolidating Balance Sheet, As Adjusted
As of October 31, 2014
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 


Cash and cash equivalents
$
54,874

 
$
16,429

 
$
198,888

 
$

 
$
270,191

Accounts receivable, net

 
400,456

 
675,515

 
(16,262
)
 
1,059,709

Inventories

 
467,602

 
750,161

 
(115,808
)
 
1,101,955

Other current assets
87,945

 
9,520

 
82,671

 
15

 
180,151

Total current assets
142,819

 
894,007

 
1,707,235

 
(132,055
)
 
2,612,006

Property, plant and equipment, net
23,660

 
346,761

 
525,642

 
(3,623
)
 
892,440

Other assets:
 
 
 
 
 
 
 
 


Other intangible assets, net

 
228,950

 
90,319

 

 
319,269

Goodwill

 
453,374

 
1,063,319

 

 
1,516,693

Deferred income taxes
1,875

 

 
70,022

 

 
71,897

Other non-current assets
4,136,777

 
2,139,776

 
2,662,560

 
(8,759,069
)
 
180,044

Total other assets
4,138,652

 
2,822,100

 
3,886,220

 
(8,759,069
)
 
2,087,903

Total assets
$
4,305,131

 
$
4,062,868

 
$
6,119,097

 
$
(8,894,747
)
 
$
5,592,349

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Short-term borrowings, including current portion of long-term obligations
$

 
$
11,634

 
$
105

 
$

 
$
11,739

Trade accounts payable
3,134

 
215,235

 
177,576

 

 
395,945

Employee compensation and benefits
11,706

 
58,307

 
66,898

 

 
136,911

Advance payments and progress billings

 
117,768

 
193,165

 
(24,994
)
 
285,939

Accrued warranties

 
17,002

 
50,270

 

 
67,272

Other accrued liabilities
94,097

 
54,523

 
124,244

 
(7,264
)
 
265,600

Current liabilities of discontinued operations

 
11,582

 

 

 
11,582

Total current liabilities
108,937

 
486,051

 
612,258

 
(32,258
)
 
1,174,988

Long-term obligations
1,269,459

 

 
82

 

 
1,269,541

Other liabilities:
 
 
 
 
 
 
 
 


Liabilities for postretirement benefits
18,743

 
866

 

 

 
19,609

Accrued pension costs
132,947

 
7,030

 
4,402

 

 
144,379

Other non-current liabilities
(12,100
)
 
7,772

 
151,800

 

 
147,472

Total other liabilities
139,590

 
15,668

 
156,202

 

 
311,460

Shareholders’ equity
2,787,145

 
3,561,149

 
5,350,555

 
(8,862,489
)
 
2,836,360

Total liabilities and shareholders’ equity
$
4,305,131

 
$
4,062,868

 
$
6,119,097

 
$
(8,894,747
)
 
$
5,592,349

Supplemental Subsidiary Guarantor Condensed Consolidated Statement of Cash Flows
Condensed Consolidating Statement of Cash Flows
Year Ended October 30, 2015
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Consolidated
Operating Activities:
 
 
 
 
 
 


Net cash provided by operating activities
261,293

 
16,105

 
77,935

 
355,333

Investing Activities:
 
 
 
 
 
 


Acquisition of businesses, net of cash acquired

 

 
(114,353
)
 
(114,353
)
Property, plant and equipment acquired
(945
)
 
(19,108
)
 
(51,283
)
 
(71,336
)
Proceeds from sale of property, plant and equipment
942

 
216

 
3,142

 
4,300

Other investing activities, net
(1,148
)
 

 
1,065

 
(83
)
Net cash used by investing activities
(1,151
)
 
(18,892
)
 
(161,429
)
 
(181,472
)
Financing Activities:
 
 
 
 
 
 


Common stock issued
4,654

 

 

 
4,654

Excess tax benefit from exercise of stock options
261

 

 

 
261

Dividends paid
(77,950
)
 

 

 
(77,950
)
Redemption of 6% note due 2016
(250,000
)
 

 

 
(250,000
)
Net borrowings under Credit Agreement
58,600

 

 

 
58,600

Change in short and other long-term obligations, net

 
(11,634
)
 
1,113

 
(10,521
)
Treasury stock purchased
(50,000
)
 

 

 
(50,000
)
Net cash used (provided) by financing activities
(314,435
)

(11,634
)

1,113


(324,956
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(16,211
)
 
(16,211
)
Decrease in cash and cash equivalents
(54,293
)
 
(14,421
)
 
(98,592
)
 
(167,306
)
Cash and cash equivalents at beginning of period
54,874

 
16,429

 
198,888

 
270,191

Cash and cash equivalents at end of period
$
581

 
$
2,008

 
$
100,296

 
$
102,885


Condensed Consolidating Statement of Cash Flows, As Adjusted
Year Ended October 31, 2014
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Consolidated
Operating Activities:
 
 
 
 
 
 


Net cash provided by operating activities of continuing operations
$
306,292

 
$
3,418

 
$
53,731

 
$
363,441

Net cash used by operating activities of discontinued operations

 
(102
)
 

 
(102
)
Net cash provided by operating activities
306,292

 
3,316

 
53,731

 
363,339

Investing Activities:
 
 
 
 
 
 

Acquisition of businesses, net of cash acquired

 

 
(44,426
)
 
(44,426
)
Property, plant and equipment acquired
(4,706
)
 
(23,130
)
 
(63,241
)
 
(91,077
)
Proceeds from sale of property, plant and equipment

 
6,512

 
3,451

 
9,963

Other investing activities, net
16

 
(1,052
)
 
1,089

 
53

Net cash used by investing activities
(4,690
)
 
(17,670
)
 
(103,127
)
 
(125,487
)
Financing Activities:

 


 


 


Common stock issued
13,346

 

 

 
13,346

Excess tax benefit from exercise of stock options
1,632

 

 

 
1,632

Dividends paid
(74,945
)
 

 

 
(74,945
)
Repayments of Term Loan
(37,500
)
 

 

 
(37,500
)
Change in short and other long-term obligations, net

 
10,422

 
(8,090
)
 
2,332

Treasury stock purchased
(269,336
)
 

 

 
(269,336
)
Financing fees
(2,826
)
 

 

 
(2,826
)
Net cash (used) provided by financing activities
(369,629
)
 
10,422

 
(8,090
)
 
(367,297
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(6,073
)
 
(6,073
)
Decrease in cash and cash equivalents
(68,027
)
 
(3,932
)
 
(63,559
)
 
(135,518
)
Cash and cash equivalents at beginning of period
122,901

 
20,361

 
262,447

 
405,709

Cash and cash equivalents at end of period
$
54,874

 
$
16,429

 
$
198,888

 
$
270,191



Condensed Consolidating Statement of Cash Flows, As Adjusted
Year Ended October 25, 2013
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Consolidated
Operating Activities:
 
 
 
 
 
 


Net cash provided by operating activities of continuing operations
$
457,171

 
$
58,565

 
$
122,802

 
$
638,538

Net cash used by operating activities of discontinued operations

 
(1,688
)
 

 
(1,688
)
Net cash provided by operating activities
457,171

 
56,877

 
122,802

 
636,850

Investing Activities:
 
 
 
 
 
 

Property, plant and equipment acquired
(8,489
)
 
(43,830
)
 
(101,099
)
 
(153,418
)
Proceeds from sale of property, plant and equipment

 
1,111

 
2,444

 
3,555

Other investing activities, net
(112
)
 

 

 
(112
)
Net cash used by investing activities
(8,601
)
 
(42,719
)
 
(98,655
)
 
(149,975
)
Financing Activities:
 
 
 
 
 
 


Common stock issued
7,575

 

 

 
7,575

Excess tax benefit from exercise of stock options
1,728

 

 

 
1,728

Dividends paid
(74,325
)
 

 

 
(74,325
)
Repayments of term loans
(50,000
)
 

 

 
(50,000
)
Change in short and other long-term obligations, net

 
(425
)
 
(6,949
)
 
(7,374
)
Treasury stock purchased
(214,106
)
 

 

 
(214,106
)
Net cash used by financing activities
(329,128
)
 
(425
)
 
(6,949
)
 
(336,502
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(8,537
)
 
(8,537
)
Increase in cash and cash equivalents
119,442

 
13,733

 
8,661

 
141,836

Cash and cash equivalents at beginning of period
3,459

 
6,628

 
253,786

 
263,873

Cash and cash equivalents at end of period
$
122,901

 
$
20,361

 
$
262,447

 
$
405,709